Verteporfin, an inhibitor of YAP–transcriptional enhanced associated domain (TEAD) interactions (31), effectively weakened cell migratory ability (Supplemental Figure 9C), tube-forming capacity (Supplemental Figure 9D), and tumor cell transendothelial migratory ability (Supplemental Figure 9E) promoted by OX40 activation. The gene discussed is TNFRSF4; the disease is neoplasm.